Reclassification of ER+ (luminal A/luminal B1 minus ER low)-like and ER- like breast tumors based on proteomic/gene and clinical outcome signatures Meeting Abstract


Authors: Wang, G.; Shah, P.; Searfoss, R.; Fantacone-Campbell, L.; Hooke, J. A.; Deyarmin, B.; Zingmark, R. N.; Somiari, S.; Liu, J.; Kvecher, L.; Mostoller, B.; Sturtz, L. A.; Raj-Kumar, P. K.; Granger, E.; Vahdat, L.; Cutler, M. L.; Bountra, C.; Sarangarajan, R.; Hu, H.; Kiebish, M. A.; Kovatich, A. J.; Narain, N. R.; Shriver, C. D.
Abstract Title: Reclassification of ER+ (luminal A/luminal B1 minus ER low)-like and ER- like breast tumors based on proteomic/gene and clinical outcome signatures
Meeting Title: 112th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 81
Issue: 13 Suppl.
Meeting Dates: 2021 Apr 10-15/May 17-21
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-07-01
Language: English
ACCESSION: WOS:000680263506002
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2021-1188
Notes: Meeting Abstract: 1188 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Linda T Vahdat
    43 Vahdat